Your browser doesn't support javascript.
loading
A topological refactoring design strategy yields highly stable granulopoietic proteins.
Skokowa, Julia; Hernandez Alvarez, Birte; Coles, Murray; Ritter, Malte; Nasri, Masoud; Haaf, Jérémy; Aghaallaei, Narges; Xu, Yun; Mir, Perihan; Krahl, Ann-Christin; Rogers, Katherine W; Maksymenko, Kateryna; Bajoghli, Baubak; Welte, Karl; Lupas, Andrei N; Müller, Patrick; ElGamacy, Mohammad.
Afiliação
  • Skokowa J; Division of Translational Oncology, Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, 72076, Tübingen, Germany. julia.skokowa@med.uni-tuebingen.de.
  • Hernandez Alvarez B; Max Planck Institute for Biology, 72076, Tübingen, Germany.
  • Coles M; Max Planck Institute for Biology, 72076, Tübingen, Germany.
  • Ritter M; Division of Translational Oncology, Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, 72076, Tübingen, Germany.
  • Nasri M; Division of Translational Oncology, Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, 72076, Tübingen, Germany.
  • Haaf J; Division of Translational Oncology, Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, 72076, Tübingen, Germany.
  • Aghaallaei N; Division of Translational Oncology, Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, 72076, Tübingen, Germany.
  • Xu Y; Division of Translational Oncology, Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, 72076, Tübingen, Germany.
  • Mir P; Division of Translational Oncology, Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, 72076, Tübingen, Germany.
  • Krahl AC; Division of Translational Oncology, Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, 72076, Tübingen, Germany.
  • Rogers KW; Friedrich Miescher Laboratory of the Max Planck Society, 72076, Tübingen, Germany.
  • Maksymenko K; Division of Developmental Biology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, 20892, USA.
  • Bajoghli B; Max Planck Institute for Biology, 72076, Tübingen, Germany.
  • Welte K; Friedrich Miescher Laboratory of the Max Planck Society, 72076, Tübingen, Germany.
  • Lupas AN; Division of Translational Oncology, Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, 72076, Tübingen, Germany.
  • Müller P; Division of Translational Oncology, Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, 72076, Tübingen, Germany.
  • ElGamacy M; Max Planck Institute for Biology, 72076, Tübingen, Germany.
Nat Commun ; 13(1): 2948, 2022 05 26.
Article em En | MEDLINE | ID: mdl-35618709
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fator Estimulador de Colônias de Granulócitos / Hematopoese Limite: Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fator Estimulador de Colônias de Granulócitos / Hematopoese Limite: Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha